Advertisement
Australia markets closed

  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     

  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     

  • AUD/USD

    0.6604
    -0.0017 (-0.26%)
     

  • OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD

    2,366.90
    +26.60 (+1.14%)
     

  • Bitcoin AUD

    91,994.07
    -3,189.84 (-3.35%)
     

  • CMC Crypto 200

    1,259.02
    -98.99 (-7.29%)
     

  • AUD/EUR

    0.6128
    -0.0010 (-0.16%)
     

  • AUD/NZD

    1.0963
    -0.0006 (-0.05%)
     

  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     

  • NASDAQ

    18,161.18
    +47.72 (+0.26%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • Dow Jones

    39,512.84
    +125.08 (+0.32%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Czech health ministry recommends AstraZeneca, J&J jabs only for over-60s

Reuters
·1-min read

PRAGUE, June 9 (Reuters) - The Czech health ministry recommended on Wednesday that only people over 60 years old should receive COVID-19 vaccines from AstraZeneca and Johnson & Johnson due to a potential risk of blood clots.

Scientists and U.S. and European drug regulators have been searching for an explanation for what is causing rare but potentially deadly clots accompanied by low blood platelet counts, which have led some countries to halt or limit use of the AstraZeneca and J&J vaccines.

The Czech health ministry said it made the decision after responding to recommendations from the country's drug regulator SUKL and the Czech Vaccination Society.

U.S., EU and other regulators have said the benefits of receiving the AstraZeneca or J&J shots outweigh any risks.

ADVERTISEMENT

Vaccinations in the country of 10.7 million have accelerated in recent weeks with Pfizer's two-dose jab making up the majority of supply in the central European nation.

(Reporting by Michael Kahn Editing by Gareth Jones)